Stay updated with breaking news from Interim Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from...
La vacuna de ADN fue aprobada para su uso de emergencia contra Covid-19 en la India; podrá administrarse a mayores de 12 años.
Clene Reports First Quarter 2021 Operating and Financial Highlights May 11, 2021 07:00 ET | Source: Clene Inc. Clene Inc. Salt Lake City, UNITED STATES Interim Phase 2 data indicate that CNM-Au8 has a homeostatic effect on brain bioenergetics and support its potential to drive meaningful neurological functional improvements in MS patients Awarded Michael J. Fox Foundation (MJFF) grant to accelerate development of CNM-Au8 as a treatment for Parkinson’s disease Phase 2 RESCUE-ALS trial and Phase 2 target engagement trials in MS and PD remain on tra...
Bharat Biotech releases Phase 3 results of Covaxin, says it shows 81% interim clinical efficacy Bharat Biotech releases Phase 3 results of Covaxin, says it shows 81% interim clinical efficacy Bharat Biotech has announced Phase 3 clinical trial results of Covaxin, saying the vaccine demonstrates interim clinical efficacy of 81 per cent. advertisement Bharat Biotech said Phase 3 clinical trials for Covaxin involved 25,800 volunteers. Bharat Biotech said the Phase 3 clinical trials for Covaxin involved 25,800 volunteers, making it the "largest trials ever conducted in India" in collaboration wit...